Deprenyl augmentation for treating negative symptoms of schizophrenia: A double-blind, controlled study

Journal of Clinical Psychopharmacology

Volumn 19, Issue 6, 1999, Pages 522-525

  Jungerman, Tal ^a   Rabinowttz, David ^a   Klein, Ehud ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PLACEBO; SELEGILINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PLACEBO EFFECT; SCHIZOPHRENIA; SELEGILINE;

EID: 0032700158     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199912000-00006     Document Type: Article

References (7)

1. Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996;153:466-76.
2. Lindenmayer JP. New pharmacotherapeutic modalities for negative symptoms in psychosis. Acta Psychiatr Scand Suppl 1995;388:15-9.
3. Pereryi A, Goswami U, Frecska E. L-deprenyl in treating negative symptoms schizophrenic patients. Psychiatry Res 1992;42:189-91.
4. Bodkin JA, Cohen BM, Salmon MS, Cannon SE, Zornberg GL, Cole JO. Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine. J Nerv Ment Dis 1996;184:295-301.
5. Lapierre YD. Placebo: a potent but misunderstood psychotrope [editorial]. J Psychiatry Neurosci 1995;20:173-4.
6. Taiminen T, Syvalahti E, Saarijarvi S, Lehto H, Ahola V, Salokangas RK. Prediction of positive placebo response among chronic schizophrenic outpatients. J Nerv Ment Dis 1996;184: 109-13.
7. Sunderland T, Cohen RM, Molchan S, Lowlor BA, Mellow AM, Newhouse PA, Tariot PN, Muller EA, Murphy DL. High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994;51:607-15.